Protective Effect of Irbesartan by Inhibiting ANGPTL2 Expression in Diabetic Kidney Disease
Lingna Fang, Shao Zhong, Liji Huang, Bing Lu, Li-Wen Shen, Fengyan Tang, He-Ping Sun, Li Zhang
Topics & Concepts
IrbesartanInternal medicineEndocrinologyMedicinePodocyteKidneyDiabetes mellitusInflammationDiabetic nephropathyImmunohistochemistryProteinuriaChemistryBlood pressureLipid metabolism and disordersCancer, Hypoxia, and MetabolismLiver Disease Diagnosis and Treatment